Be prepared with your policy number and specific questions about Semaglutide coverage
The role of the inflammasome in heart failure
Betul Ibis and colleagues, used the TriNetX database to compare 217,302 diabetes patients on GLP-1 medications with 217,302 matched patients on DPP-4 inhibitors. Patients on GLP-1s had a significantly lower risk of developing rheumatoid arthritis (HR = 0.87, p = 0.026), gout, and osteoarthritis within one year
Not gone, but noticeably less intrusive
Reporting headaches from GLP-1 to your doctor is essential, especially if they are paired with other side effects like vision changes, dizziness, or vomiting
Do you have a tip on a health story that Newsweek should be covering